<HashMap><database>GEO</database><file_versions><headers><Content-Type>application/xml</Content-Type></headers><body><files><Other>ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE325nnn/GSE325402/</Other></files><type>primary</type></body><statusCode>OK</statusCode><statusCodeValue>200</statusCodeValue></file_versions><scores/><additional><omics_type>Transcriptomics</omics_type><species>Homo sapiens</species><gds_type>Expression profiling by high throughput sequencing</gds_type><full_dataset_link>https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE325402</full_dataset_link><repository>GEO</repository><entry_type>GSE</entry_type></additional><is_claimable>false</is_claimable><name>EGF-induced EMT in MDA-MB-468 breast cancer cell line</name><description>The Epithelial-Mesenchymal Transition (EMT) is an early metastatic process found to promote disease progression and poor prognosis in cancer. Here, EMT was induced in the breast cancer cell line MDA-MB-468 using epidermal growth factor (EGF). Gene expression data was used to determine effects on metabolic pathways, as well as to assess the degree of EMT induction.</description><dates><publication>2026/04/01</publication></dates><accession>GSE325402</accession><cross_references><GSM>GSM9602508</GSM><GSM>GSM9602507</GSM><GSM>GSM9602509</GSM><GSM>GSM9602515</GSM><GSM>GSM9602504</GSM><GSM>GSM9602514</GSM><GSM>GSM9602503</GSM><GSM>GSM9602506</GSM><GSM>GSM9602516</GSM><GSM>GSM9602505</GSM><GSM>GSM9602511</GSM><GSM>GSM9602500</GSM><GSM>GSM9602510</GSM><GSM>GSM9602499</GSM><GSM>GSM9602513</GSM><GSM>GSM9602502</GSM><GSM>GSM9602512</GSM><GSM>GSM9602501</GSM><GSM>GSM9602498</GSM><GSM>GSM9602497</GSM><GPL>18573</GPL><GSE>325402</GSE><taxon>Homo sapiens</taxon></cross_references></HashMap>